BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 25629589)

  • 21. Elevated Monoamine Oxidase-A Distribution Volume in Borderline Personality Disorder Is Associated With Severity Across Mood Symptoms, Suicidality, and Cognition.
    Kolla NJ; Chiuccariello L; Wilson AA; Houle S; Links P; Bagby RM; McMain S; Kellow C; Patel J; Rekkas PV; Pasricha S; Meyer JH
    Biol Psychiatry; 2016 Jan; 79(2):117-26. PubMed ID: 25698585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron Emission Tomography Studies of the Glial Cell Marker Translocator Protein in Patients With Psychosis: A Meta-analysis Using Individual Participant Data.
    Plavén-Sigray P; Matheson GJ; Collste K; Ashok AH; Coughlin JM; Howes OD; Mizrahi R; Pomper MG; Rusjan P; Veronese M; Wang Y; Cervenka S
    Biol Psychiatry; 2018 Sep; 84(6):433-442. PubMed ID: 29653835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography.
    Rekkas PV; Wilson AA; Lee VW; Yogalingam P; Sacher J; Rusjan P; Houle S; Stewart DE; Kolla NJ; Kish S; Chiuccariello L; Meyer JH
    JAMA Psychiatry; 2014 Aug; 71(8):873-9. PubMed ID: 24898155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated monoamine oxidase a binding during major depressive episodes is associated with greater severity and reversed neurovegetative symptoms.
    Chiuccariello L; Houle S; Miler L; Cooke RG; Rusjan PM; Rajkowska G; Levitan RD; Kish SJ; Kolla NJ; Ou X; Wilson AA; Meyer JH
    Neuropsychopharmacology; 2014 Mar; 39(4):973-80. PubMed ID: 24154665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging Microglial Activation in Individuals at Clinical High Risk for Psychosis: an In Vivo PET Study with [
    Hafizi S; Da Silva T; Gerritsen C; Kiang M; Bagby RM; Prce I; Wilson AA; Houle S; Rusjan PM; Mizrahi R
    Neuropsychopharmacology; 2017 Dec; 42(13):2474-2481. PubMed ID: 28604733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study.
    Da Silva T; Hafizi S; Rusjan PM; Houle S; Wilson AA; Prce I; Sailasuta N; Mizrahi R
    J Psychiatry Neurosci; 2019 Mar; 44(2):111-119. PubMed ID: 30255837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microglial activation in Parkinson's disease using [
    Ghadery C; Koshimori Y; Coakeley S; Harris M; Rusjan P; Kim J; Houle S; Strafella AP
    J Neuroinflammation; 2017 Jan; 14(1):8. PubMed ID: 28086916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Modest Increase in
    Schubert JJ; Veronese M; Fryer TD; Manavaki R; Kitzbichler MG; Nettis MA; Mondelli V; Pariante CM; Bullmore ET; ; Turkheimer FE
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jul; 6(7):716-724. PubMed ID: 33515765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vivo Imaging of Translocator Protein in Long-term Cannabis Users.
    Da Silva T; Hafizi S; Watts JJ; Weickert CS; Meyer JH; Houle S; Rusjan P; Mizrahi R
    JAMA Psychiatry; 2019 Dec; 76(12):1305-1313. PubMed ID: 31532458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. State-associated changes in longitudinal [
    De Picker L; Ottoy J; Verhaeghe J; Deleye S; Wyffels L; Fransen E; Kosten L; Sabbe B; Coppens V; Timmers M; de Boer P; Van Nueten L; Op De Beeck K; Oberacher H; Vanhoenacker F; Ceyssens S; Stroobants S; Staelens S; Morrens M
    Brain Behav Immun; 2019 Mar; 77():46-54. PubMed ID: 30503836
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Ottoy J; De Picker L; Verhaeghe J; Deleye S; Wyffels L; Kosten L; Sabbe B; Coppens V; Timmers M; van Nueten L; Ceyssens S; Stroobants S; Morrens M; Staelens S
    J Nucl Med; 2018 Aug; 59(8):1267-1274. PubMed ID: 29326362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cocaine abuse in humans is not associated with increased microglial activation: an 18-kDa translocator protein positron emission tomography imaging study with [11C]PBR28.
    Narendran R; Lopresti BJ; Mason NS; Deuitch L; Paris J; Himes ML; Kodavali CV; Nimgaonkar VL
    J Neurosci; 2014 Jul; 34(30):9945-50. PubMed ID: 25057196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [¹¹C]PBR28 PET study.
    Hannestad J; DellaGioia N; Gallezot JD; Lim K; Nabulsi N; Esterlis I; Pittman B; Lee JY; O'Connor KC; Pelletier D; Carson RE
    Brain Behav Immun; 2013 Oct; 33():131-8. PubMed ID: 23850810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of psychosocial risk factors for mental health with a brain marker altered by inflammation: A translocator protein (TSPO) PET imaging study.
    Dahoun T; Calcia MA; Veronese M; Bloomfield P; Reis Marques T; Turkheimer F; Howes OD
    Brain Behav Immun; 2019 Aug; 80():742-750. PubMed ID: 31112791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia.
    Notter T; Coughlin JM; Gschwind T; Weber-Stadlbauer U; Wang Y; Kassiou M; Vernon AC; Benke D; Pomper MG; Sawa A; Meyer U
    Mol Psychiatry; 2018 Feb; 23(2):323-334. PubMed ID: 28093569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein.
    Gershen LD; Zanotti-Fregonara P; Dustin IH; Liow JS; Hirvonen J; Kreisl WC; Jenko KJ; Inati SK; Fujita M; Morse CL; Brouwer C; Hong JS; Pike VW; Zoghbi SS; Innis RB; Theodore WH
    JAMA Neurol; 2015 Aug; 72(8):882-8. PubMed ID: 26052981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation.
    Albrecht DS; Forsberg A; Sandström A; Bergan C; Kadetoff D; Protsenko E; Lampa J; Lee YC; Höglund CO; Catana C; Cervenka S; Akeju O; Lekander M; Cohen G; Halldin C; Taylor N; Kim M; Hooker JM; Edwards RR; Napadow V; Kosek E; Loggia ML
    Brain Behav Immun; 2019 Jan; 75():72-83. PubMed ID: 30223011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of cannabinoid receptor type 2, but not TSPO, in senescence-accelerated neuroinflammation in mice: a positron emission tomography study.
    Yamagishi S; Iga Y; Nakamura M; Takizawa C; Fukumoto D; Kakiuchi T; Nishiyama S; Ohba H; Tsukada H; Sato K; Ouchi Y
    J Neuroinflammation; 2019 Nov; 16(1):208. PubMed ID: 31707986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis.
    Conen S; Gregory CJ; Hinz R; Smallman R; Corsi-Zuelli F; Deakin B; Talbot PS
    Mol Psychiatry; 2021 Sep; 26(9):5398-5406. PubMed ID: 32606376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TSPO expression and brain structure in the psychosis spectrum.
    Hafizi S; Guma E; Koppel A; Da Silva T; Kiang M; Houle S; Wilson AA; Rusjan PM; Chakravarty MM; Mizrahi R
    Brain Behav Immun; 2018 Nov; 74():79-85. PubMed ID: 29906515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.